Linerixibat Long-term Safety, and Tolerability Study
NCT04167358
·
clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
242
Enrollment
INDUSTRY
Sponsor class
Conditions
Cholestasis
Interventions
DRUG:
Linerixibat
Sponsor
GlaxoSmithKline